title: Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.
authors.affiliation: Department of Clinical Research, Sandoz Pharma Ltd, Basle, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Taesch
authors.forename: D
authors.initials: D
authors.lastname: Niese
authors.forename: E A
authors.initials: EA
authors.lastname: Mueller
mesh_terms: D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use / Q000633:toxicity*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D013997:Time Factors
chemical_list: D016572:Cyclosporine; D003404:Creatinine